Publications by authors named "Alessandro Bertolini"

Claim this Profile
O
Optimizing Lung Cancer Diagnostics: Insights from a Fast-Track Program in a Complex Healthcare Setting.
Paolo Scanagatta, Alessandro Bertolini, Giuseppe Naldi, Francesca Antoniazzi, Francesco Inzirillo

Life (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study.
Matteo Conti, Elena Bolzacchini, Giovanna Luchena, Lorenza Bertu', Paola Tagliabue, Alessandro Bertolini

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Nicla La Verde, Giovanna Damia, Ornella Garrone, Daniele Santini, Alessandra Fabi, Alessandro Stefano Bertolini

Breast Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study.
Roberto Moretto, Mirella Giordano, Anello M Poma, Alessandro Passardi, Alessandra Boccaccino, Alessandro S Bertolini

Eur J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gas Damping in Capacitive MEMS Transducers in the Free Molecular Flow Regime.
Boris A Boom, Alessandro Bertolini, Eric Hennes, Johannes F J van den Brand

Sensors (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covid19: Could other alternatives have been possible?
Alessandro Bertolini, Martina Maiolani, Elisabetta Menatti, Claudio Barbonetti, Francesco Stiglich

J Glob Antimicrob Resist· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial.
Marco Platania, Felice Pasini, Luca Porcu, Mattia Boeri, Francesco Verderame, Alessandro Bertolini

Lung Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Maria Di Bartolomeo, Monica Niger, Federica Morano, Salvatore Corallo, Maria Antista, Alessandro Bertolini

BMC Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Thanyanan Reungwetwattana, Kazuhiko Nakagawa, Byoung Chul Cho, Manuel Cobo, Eun Kyung Cho, Alessandro Bertolini

J Clin Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study.
Maria Di Bartolomeo, Monica Niger, Giuseppe Tirino, Angelica Petrillo, Rosa Berenato, Alessandro Bertolini

Target Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer.
Filippo DE Marinis, Paolo Bidoli, Andrea Luciani, Domenico Amoroso, Giuseppe Tonini, Alessandro Bertolini

Anticancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the room temperature payload prototype for the cryogenic interferometric gravitational wave detector KAGRA.
Fabián Erasmo Peña Arellano, Takanori Sekiguchi, Yoshinori Fujii, Ryutaro Takahashi, Mark Barton, Alessandro Bertolini

Rev Sci Instrum· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
Antonio Avallone, Maria Carmela Piccirillo, Luigi Aloj, Guglielmo Nasti, Paolo Delrio, Alessandro Bertolini

BMC Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Monica Ganzinelli, Eliana Rulli, Elisa Caiola, Marina Chiara Garassino, Massimo Broggini, Alessandro Bertolini

Sci Rep· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study.
Lorenzo Antonuzzo, Elisa Giommoni, Davide Pastorelli, Tiziana Latiano, Ida Pavese, Alessandro Bertolini

World J Gastroenterol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.
Maria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, Sandro Barni, Claudio Verusio

Eur J Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.
Daniele Fagnani, Luciano Isa, Magda Franca Verga, Paola Nova, Clelia Casartelli, Alessandro Bertolini

Tumori· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.
Nicola Silvestris, Francesco Pantano, Toni Ibrahim, Teresa Gamucci, Fernando De Vita, Alessandro Bertolini

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.
Diego Cortinovis, Giordano Beretta, Elena Piazza, Giovanna Luchena, Stefania Aglione, Alessandro Bertolini

Tumori· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.
Luigi Celio, Sergio Frustaci, Angela Denaro, Angela Buonadonna, Antonio Ardizzoia, Alessandro Bertolini

Support Care Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations.
Gabriella Farina, Flavia Longo, Olga Martelli, Ida Pavese, Andrea Mancuso, Alessandro Bertolini

Clin Lung Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
Daniele Fagnani, Alessandro Bertolini, Laura Catena, Maurizio Tomirotti, Marilena Visini

Blood Coagul Fibrinolysis· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer.
Antonio Ardizzoia, Ilaria Colombo, Monica Giordano, Stefania Aglione, Luciano Isa, Alessandro Bertolini

Tumori· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
Silvia Ferrari, Bianca Rovati, Camillo Porta, Paolo Emilio Alessandrino, Alessandro Bertolini

Cancer Immunol Immunother· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3.0 Tesla Magnetic Resonance. Part 2: morphological and functional brain imaging.
Tommaso Scarabino, Giuseppe Maria Giannatempo, Francesco Nemore, Francesco Di Salle, Fabrizio Esposito, Alessandro Bertolini

Radiol Med· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis